TrialBlood cancer journal2018
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia.
Patricia Johansson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
40 papers cite it
this paperpooled itcites it
TrialBlood cancer journal2018
Patricia Johansson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.